Paul from Switzerland

Registered at the short selling broker FirsTrade, 3 minutes ago.

» Try FirsTrade you too
Don't show again

Artivion Inc (AORT) shares information

Artivion Inc


24h Change

-3.87 %

AORT

Live rate:

Stock data per Wednesday 5 Oct, 2022

AORT
NEW YORK STOCK EXCHANGE INC.
13.56
13.5
13.04
-0.525 (-3.87%)
US Market is open

Live Stock price in graph for Artivion Inc (AORT)

Data updated continously for AORT, showing up to the 500 most recent 100 data points

  • Latest Volume

    31,687 (-92.65 %)

  • Volume prev. day

    430,856

  • Avg. daily volume

    309,946

  • Market cap

    525,519,764

  • P/E ratio

    -30.19

  • Today high

    13.66 USD

  • Today low

    13.005 USD

  • 52 week high

    23.43 USD

  • 52 week low

    12.9 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Artivion Inc

Below you can find the most recent news posts about Artivion Inc, primarily from US and UK based news sources.

Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver (NYSE:AORT)

Tuesday, 27 September 2022, 23:48:54
Artivion”s decision to pull PROACT Xa trial resulted in heavy downside for its share price. Investors sold positions rapidly such that AORT stock trades at multi-year lows. Read more here.
— Seeking Alpha


Artivion Inc. PT Lowered to $28 at Lake Street Capital Markets

Tuesday, 27 September 2022, 14:58:03
https://www.investing.com/news/pro/artivion-inc-pt-lowered-to-28-at-lake-street-capital-markets-432SI-2899854
— Investing.com


Artivion Falls After Stopping Proact Xa Clinical Trial

Friday, 23 September 2022, 16:27:37
Shares of Artivion, Inc. (AORT) are tumbling more than 19 percent on Friday morning trade after the cardiac and vascular surgery company announced that it has stopped the PROACT Xa clinical trial based on the recommendation of the independent Data and Safety Monitoring Board of the trial due to lack of evidence. The study was evaluating the use of Apixaban in patients treated with mechanical aortic valves.
— RTT News


Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance

Friday, 23 September 2022, 16:08:14
Full story available on Benzinga.com
— Benzinga


Athersys, Global Cord top healthcare gainers; Avenue, Artivion lead losers” pack

Friday, 23 September 2022, 16:05:31
Athersys ATHX +22%. Global Cord Blood (CO) +13%. Avenue Therapeutics (ATXI) -23%. Artivion AORT -20%.
— Seeking Alpha


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have AORT available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.